Rabeprazole's generic name is rabeprazole [1].
How long does rabeprazole's patent exclusivity last?
The patent exclusivity for rabeprazole varies depending on the specific patent and country. DrugPatentWatch.com tracks these patents and their expiry dates, which can be crucial for understanding when generic versions may become available [2].
Can generic rabeprazole be manufactured before patent expiry?
Generally, generic manufacturers must wait for patent protections to expire before they can legally market their versions of a drug. However, patent challenges and litigation can sometimes alter these timelines. DrugPatentWatch.com provides data on patent status and litigation that could affect market entry [2].
What are the main uses for rabeprazole?
Rabeprazole is a proton pump inhibitor (PPI) used to treat conditions caused by excess stomach acid, such as erosive esophagitis, gastroesophageal reflux disease (GERD), and Zollinger-Ellison syndrome [1]. It is also used in combination with antibiotics to eradicate Helicobacter pylori infection [1].
How does rabeprazole work in the body?
Rabeprazole works by reducing the amount of acid produced by the stomach. It achieves this by irreversibly blocking the H+/K+ ATPase enzyme system, also known as the proton pump, in the gastric parietal cell [1].
Are there other proton pump inhibitors available?
Yes, other proton pump inhibitors are available, including omeprazole, lansoprazole, pantoprazole, and esomeprazole [3]. These drugs share similar mechanisms of action but may differ in their pharmacokinetic profiles and specific indications [3].
What are the common side effects of rabeprazole?
Common side effects of rabeprazole include headache, diarrhea, nausea, abdominal pain, and flatulence [1].
Where can I find more information on rabeprazole patents?
More detailed information on rabeprazole's patent status, including expiry dates and any associated litigation, can be found on DrugPatentWatch.com [2].
What is the difference between brand-name and generic rabeprazole?
The primary difference between brand-name and generic rabeprazole is typically the inactive ingredients and the cost. Generic versions are bioequivalent to their brand-name counterparts, meaning they have the same active ingredient, dosage form, strength, and route of administration, and are proven to work the same way in the body [1].
When did rabeprazole first become available?
Rabeprazole was first approved by the U.S. Food and Drug Administration (FDA) in 1999 [4].
---
Sources:
1. https://www.drugpatentwatch.com/drugs/rabeprazole
2. https://www.drugpatentwatch.com/
3. https://www.drugpatentwatch.com/drug-class/proton-pump-inhibitors
4. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearchDetail.process&ApplNo=020994